Transgenic mice expressing ApoC3 exhibit persistent hypertriglyceridemia from birth, while ApoC3 deficiency in mice leads to enhanced TG hydrolysis and clearance, resulting in reduced circulating TG levels [30–33]. This evidence concerns the gene APOC3 and hypertriglyceridemia.